Induction of labor rates in Australia have surged to 43% for first-time mothers, yet perinatal mortality rates remain largely unchanged. Clinical reliance on five major trials—35-39, INDEX, ARRIVE, SWEPIS, and the BIG BABY study—often overlooks significant methodological limitations, including low participation rates and the use of composite outcomes that mask rare events. These studies fail to provide definitive evidence that routine induction for older mothers, post-date pregnancies, or suspected large babies improves neonatal outcomes compared to expectant management. Furthermore, ultrasound estimations for fetal weight possess poor predictive value, leading to unnecessary interventions. Prioritizing continuity of care and individualized surveillance allows for more accurate risk assessment and respects maternal autonomy. Moving beyond a risk-averse, medicalized framework toward relationship-based care ensures that birth decisions are informed by personal circumstances rather than generalized, often misinterpreted, clinical data.
Sign in to continue reading, translating and more.
Open full episode in Podwise
